FGFR2b inhibitor monoclonal antibody

This page covers all FGFR2b inhibitor monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting FGFR2b (Fibroblast Growth Factor Receptor 2b).

Targets

FGFR2b (Fibroblast Growth Factor Receptor 2b)

Phase 2 pipeline (1)

• FPA144 · Amgen · Oncology
  FPA144 is a monoclonal antibody that blocks fibroblast growth factor receptor 2b (FGFR2b) to inhibit tumor growth and angiogenesis.

Patent intelligence

• fgfr2b inhibitor monoclonal antibody patent landscape — aggregated cliff calendar, attackable patents, originator estates